AIVF's AI-driven fertility treatments expand to Australia
AIVF's AI-driven fertility treatments expand to Australia
Follows five years of research to improve success rates.
Australian patients can now access AI-driven technology from Israeli start-up AIVF as part of their fertility journey.
Already available in the UK, EU, US and other locations worldwide, AIVF is a leading innovator in fertility technology which is said to increase the average number of healthy pregnancies by 30% when embryos are chosen using the AIVF program.
AIVF's technology is designed to accelerate the time to pregnancy and increase predicted clinical pregnancy success rates, by using advanced artificial intelligence. The inclusion in the Australian market ensures that patients now have access to some of the most sophisticated and well-tested fertility technologies available.
This achievement is the result of five years of intensive research, during which tens of thousands of embryos were analyzed using state-of-the-art AI models and data from five continents.
“We are excited to bring our innovative solutions to Australia, marking a significant step forward in our mission to support individuals and couples on their journey to parenthood,” said Daniella Gilboa, CEO and Co-founder of AIVF.
“Our technology is designed to provide a higher standard of care, improving clinical outcomes and optimising the IVF process.”
AIVF’s platform enhances the IVF process through predictive analytics and decision support for all Relevant Health Professionals - such as a registered medical practitioner.
This technology aims to improve success rates and optimize outcomes for fertility treatment patients, from early-stage embryo evaluation to genetic testing.
Clinics in Australia can now integrate AIVF’s solutions into their offerings, providing speedier, more accurate, and seamless IVF treatments. Patients will benefit from less invasive procedures, greater transparency, and higher success rates, ultimately leading to faster times to pregnancy.